Dr. Maria Fernanda Lara


Professional Experience

2013 – now: Senior Post Doctoral in HUVV (IBIMA; Málaga, Spain)
2010 2012: Post Doctoral in TransDerm INC. (CA, USA)
2007 – 2010:  Post Doctoral in Stanford University. (CA, USA)
2003 2007:  Predoctoral in CIEMAT (Madrid, Spain)

Expertise and Research Interests

  • Urology
  • Urine Incontinence
  • Dermatology
  • Oncology

Selected Publications

  1. Stress urinary incontinence animal models as a tool to study cell-based regenerative therapies targeting the urethral sphincter. Herrera-Imbroda B*, Lara MF, et al.  Adv Drug Deliv Rev. 2015 Mar;82-83:106-16. doi: 10.1016/j.addr.2014.10.018. Epub 2014 Oct 23.
  2. p21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia. Saiz-Ladera C*, Lara MF*, et al.. * These two authors contributed equally to this work. Oncogene. 2014 Sep 11;33(37):4599-4612. doi: 10.1038/onc.2013.417. Epub 2013 Oct 14.
  3. Partial proteasome inhibitors induce hair follicle growth by stabilizing β-catenin. Yucel G, et al. Stem Cells. 2014 Jan;32(1):85-92. doi: 10.1002/stem.1525.
  4. State-dependent signaling by Cav1.2 regulates hair follicle stem cell function. Yucel G, et al.Genes Dev. 2013 Jun 1;27(11):1217-22
  5. Inhibition of CD44 gene expression in human skin models, using self-delivery short interfering RNA administered by dissolvable microneedle arrays.
    Lara MF, et al.. Hum Gene Ther. 2012 Aug;23(8):816-23. doi: 10.1089/hum.2011.211. Epub 2012 Jun 5.

Relevante para este COST:

PDE5A Polymorphisms Influence on Sildenafil Treatment Success. Marchal-Escalona C, et al.* These two authors contributed equally to this work. J Sex Med. 2016 Jul;13(7):1104-10. doi: 10.1016/j.jsxm.2016.04.075. Epub 2016 May 24.